Bushra is a 4th year pharmacy honours student at the University of Sydney. She is passionate about patient-centred and equitable healthcare and strives to improve culturally safe healthcare for First Nations peoples. She is currently undertaking an honours research project based in Dubbo to inform the culturally safe implementation of a transition of care program. She has worked in a small community pharmacy in Maroubra for almost 4 years and has found it extremely rewarding. Thank you to the Virtual Clinical Pharmacy Service team in the Western New South Wales Local Health District for their support and invaluable knowledge towards the project.

Alice is a second-year PhD candidate at Monash University focusing on the optimisation of dosing regimens of antibiotics to overcome the antimicrobial resistance crisis. She has been the Student Representative of both the Population Approach Group of Australia and New Zealand (PAGANZ) and the ASCEPT Drug Disposition and Response Special Interest Group. She is passionate about connecting with people and sharing science.

Viet Tin Pham is a Ph.D. student at the School of Biomedical Sciences, University of Queensland. His major research interests include in vivo pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents in murine infection models and bioanalysis of murine plasma microsamples. Viet Tin’s current research focuses on the preclinical development of an antibiotic adjuvant for treating multidrug-resistant bacterial infections."

Jihye Han is a 4th year pharmacy student at The University of Queensland. Her academic pursuit includes a supervised independent research project, which focuses on calcium signalling and gene transcription. She has also received multiple Dean’s Commendation for Academic Excellence awards throughout her study. Outside of uni, Jihye works in a community pharmacy and enjoys going out for walks and watching wildlife documentaries. Her goal is to gain diverse experiences to expand my perspective and skill set, enabling her to provide valuable insights that enhance patient care.

I am a PhD candidate with the Centre for Medicines Use and Safety (CMUS) at Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences. My background as a hospital pharmacist in a large tertiary teaching hospital has allowed me to gain practical experience in both clinical and research settings. I completed my Masters of Pharmacy with Monash University in 2021, where I won Best Project Poster and Presentation for my cohort. I am excited to continue my research in investigating how benzodiazepine receptor agonists can be safely and effectively deprescribed in people living with dementia.

Andrew Rowland is a Professor of Clinical Pharmacology at Flinders University. He leads a highly productive team of researchers at the forefront of advancing extracellular vesicle isolation and analysis for use with human biospecimens. Andrew’s team are world leaders in the isolation and characterisation of tissue specific extracellular vesicles from blood and work closely with industry and clinicians to apply this technology to improve patient outcomes by enhancing drug efficacy and minimising harms. Andrew’s 143 peer-reviewed manuscripts have been cited more than 6,500 times, reflecting the high impact of his research, Andrew’s five-year field-weighted citation index of 7.74. Andrew holds leadership roles across multiple professional societies, including ASCEPT, where he severs on the society’s Board of Directors and is actively involved in philanthropic initiatives, through organisations including Flinders Foundation, Starlight and Tour de Cure.

Liam O’Callaghan is a PhD student and Assistant Teaching Fellow at Bond University. After completing an accelerated Bachelor of Biomedical Science degree in 2020, Liam developed a keen interest in research and laboratory techniques. This led him to complete a First-Class Honours project on repurposing alpha-1 antagonists to treat prostate cancer, which yielded promising results. Liam’s PhD project, which is on track for completion in mid-2025, is now assessing the efficacy of the same drug class in treating bladder cancer. Liam is also passionate about shaping the future of researchers and clinical practitioners alike, enjoying a busy schedule of teaching alongside his own academic pursuits.

Nancy (Yanxi Chang) is a third-year Ph.D. candidate at the Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia. Her research focuses on Drug Discovery Biology, specifically in RGS protein fine tuning GLP-1R function. Nancy earned her B.S. and M.S. in Chinese Materia Medica in China.

I am Ching Chen, a pharmacology Ph.D. candidate at National Yang-Ming Chiao Tung University. My research focuses on vascular medicine, molecular biology, diabetes mellitus, and kidney disease, with expertise in experimental animal model design and drug development. My research is dedicated to understanding the role of the chemokine CXCL5 in diabetes and its complications. I have extensively explored the bidirectional interactions of CXCL5 in diabetic nephropathy and its potential therapeutic mechanisms. Through both in vitro and in vivo experiments, I have demonstrated the significant impact of CXCL5 on diabetic nephropathy. These findings highlight my deep understanding and innovative contributions to the field.

Vineesha Veer, BBiomedSci (Hon.), is a doctoral student researching the physiology and pharmacology of the lower urinary tract at the Centre for Urology Research, Faculty of Health Sciences and Medicine, Bond University. Vineesha's research aims is to identify any alternative mechanisms of antimuscarinics for patients with overactive bladder, to potentially better patient's compliance and outcomes when prescribed this drug class. Vineesha also has a passion for medical education and teaches a variety of physiology and pharmacology based subjects at Bond University.

Dr. Christopher Choy is a postdoctoral researcher in the Drug Discovery Biology lab at Monash University's Institute of Pharmaceutical Sciences. He earned his PhD in Pharmacology from the University of Melbourne and specialises in neuropharmacology and preclinical drug discovery. His recent work focuses on muscarinic acetylcholine receptor modulation for schizophrenia treatment and the development of animal models for schizophrenia. He is one of the recipients of a recent NHMRC Ideas Grant and has co-authored over 20 publications, garnering more than 800 citations (H-index: 16). Additionally, he is a dedicated mentor to early-career researchers and research students.

Brendan recently completed his PhD in the laboratory of Nicola Smith at UNSW Sydney. He is now a Lecturer in the Department of Pharmacology in the School of Biomedical Sciences at UNSW Sydney. Brendan has a special interest in G protein-coupled receptors, particularly those that do not yet have an identified endogenous ligand which are termed “orphans”. Brendan is the chair-elect of the ASCEPT Equity, Diversity, and Inclusion Committee and is committed to improving the visibility of the ASCEPT LGBTQIA+ community.

My PhD research focused on evaluating the GSK3β inhibitory activity of 3,5-disubstituted indoline-2-one derivatives as potential therapeutic agents for type 2 diabetes mellitus and acute inflammation. After defending my PhD, I moved to Taiwan and joined Prof. Chi-Ming Chan and Prof. Wan-Wan Lin's project as a postdoctoral researcher. Our work explored the role of AMPK in diabetic retinopathy. My specific research focused on investigating the role of the CASK protein and AMPK in the effects of UVA light on retinal Müller cells.

Keith is a full-time research assistant at the Graduate Institute of Pharmacology, National Taiwan University, holding a Master degree in Pharmacology from National Taiwan University and a Bachelor’s degree in Medical Biotechnology from Sunway University. Highly enthusiastic and driven by a passion for scientific discovery, Keith has developed a strong foundation in both theoretical knowledge and practical lab skills, particularly in the fields of pharmacology, biotechnology, and molecular biology. During Keith’s research in graduate programme, he focused on dissecting the novel functional role of CASK in H2O2-induced cell death and inflammation in microglial through using different molecular biology technique. Besides, during his undergraduate studies, he participated in a final year project on the development of a vaccine for SARS-CoV-2, further demonstrate their ability to apply scientific principles to pressing global health challenges.

Yeoh Chuin Shung is a dedicated researcher with a master's degree in pharmacology from the Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, where he is also currently posted at. He previously earned his bachelor's degree in biotechnology and bio-industrial science from National Cheng Kung University, Taiwan. Currently serving as a research assistant, Yeoh focuses on studying CASK and its critical role in calcium signalling and mitochondrial regulation of cell death. His work reflects a passion for uncovering molecular mechanisms that drive cellular processes and aims to contribute meaningfully to the fields of pharmacology and cell biology. Outside the lab, he remains committed to continuous learning and scientific discovery.

Thilini is a dedicated academic with a multifaceted career as a pharmacist, teacher, and researcher. Her research activities focus on improving chronic disease management among culturally and linguistically diverse (CALD) populations and optimising the quality use of complementary medicines. Her research aims to identify strategies to prevent and manage cardiometabolic diseases. Thilini employs a variety of methodologies, including qualitative interviews and intervention trials, to develop and implement strategies that enhance the quality of care provided to people from CALD backgrounds. Thilini is also interested in exploring innovative approaches to improving the quality use of complementary medicines, striving to bridge the gap between traditional and modern medicine. Her research endeavours focus on enhancing the understanding and application of complementary medicines through dosage form design, aiming to ensure their safe and effective integration into healthcare practices.

Phurinut graduated high school from Benchama Maharat and is now studying at the Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Millicent (First Class Honours in Biomedical Research, and top 2% of cohort) is a PhD Candidate investigating how decreased oxygen, and maternal medications during pregnancy including antenatal corticosteroids, impact the programming of drug metabolism for the offsprings’ lifetime. She is utilising established preclinical models developed at the University of Cambridge and the University of South Australia to explore hepatic cytochrome P450 activity, which are responsible for the phase I metabolism of approximately 80% of clinical medications. Millicent completed an internship at the Future Industries Institute focussing on material chemistry on a project with industry collaboration. These experiences have added to her diverse background and inspired her interest in cross-disciplinary research. She is currently collaborating with a Neonatologist and Researcher from the Women’s and Children’s to explore how antenatal steroids affect placental cytochrome P450 activity.

Anika Nagarajan is a fourth-year Pharmacy (Honours) student majoring in Clinical and Experimental Therapeutics at the University of Queensland. She is an accomplished student with a passion for enhancing people’s lives through actively promoting and offering quality patient-centred care. She holds a GPA of 6.8 and has earned 5 Dean’s commendation for academic excellence awards, as well as the esteemed UQ Scholarship, “Pharmacy Interest Women’s Group Prize”. Anika holds practical experience as a pharmacy student with United Chemists, and placement experience at Mater and Royal Brisbane and Women’s Hospital, and rural areas including Chinchilla. She enjoys mentorship and facilitating welcoming learning environments. Anika has held such positions, including volunteering as a Pharmacy Peer Mentor at UQ and is eager to explore the wide range of opportunities available in pharmacy to elevate her skill set and she is committed to positively contributing to the pharmacy field.

Goran Gajski, PhD is a Senior Scientific Associate at the Institute for Medical Research and Occupational Health in Zagreb, Croatia with a scientific background in biochemistry and molecular biology. In genetic toxicology, he uses various methodological approaches, both in vitro and in vivo, on different cell and animal models to investigate the effects of various physical and chemical agents on organisms, tissues, cells, and cell structures with special emphasis on the DNA molecule. Moreover, the scope of his work also comprises human biomonitoring studies in different environmental and occupational settings. He was involved in several national and international projects as principal investigator and team member and has published more than 130 papers and book chapters that have been cited more than 5000 times with an h-index of 38 (by Google Scholar). For his work he received several national and international scientific awards, among other the Danubius Young Scientist Award issued by the Austrian Federal Ministry of Science and the National Award for Science in the Field of Natural Sciences issued by the Croatian Parliament. Currently, he is a chair of the International Comet Assay Group an affiliated group of the European Environmental Mutagenesis and Genomics Society. He is a European Registered Toxicologist (ERT) and Editorial Board member of the journal Medicine®.

Dr Xin (Cindy) Zhang received her PhD in 2021 and was awarded the 2021 Mollie Holman Medal for doctoral thesis excellence by Monash University for studies on the glucagon-like peptide-1 receptor (GLP-1R) in the lab of Profs. Patrick Sexton and Denise Wootten. She was then recruited as a Postdoctoral Fellow in the same laboratory on projects aligned to the Australian Research Council (ARC) Centre for Cryo-EM of Membrane Proteins (CCeMMP), and was recently awarded an ARC Discovery Early Career Researcher Award (DECRA) fellowship (2023-2026). Her research program incorporates cell biology, biochemistry, structural biology (in particular cryo-EM) and pharmacology to gain molecular insights into G protein-coupled receptors (GPCRs). Her particular interest is in the structure-function relationships of glucagon family GPCRs to understand how diverse ligands bind to and activate these receptors, which are clinically important drug targets for the treatment of type II diabetes and obesity.

MinWu Chao is an Assistant Professor at National Sun Yat-sen University in Taiwan. She teaches Pharmacology in the Post-Baccalaureate Medicine Program. Her research focuses on drug discovery and development in the field of cancer.

Dr Julie Stevens is a Senior Lecturer and Program Manager at RMIT University. She is a registered pharmacist with experience across hospital and community pharmacy settings. Her research focus is on clinical research within areas of diabetes, gastrointestinal function, and aged care, and pharmacy practice research focused on digital health technologies, health literacy and clinical interventions.

Dr. Chihiro Tohda was earned Ph.D. (Pharmaceutical Science) from Hokkaido University in 1994. She worked as a Research Fellowship for Young Scientists of JSPS and became an Assistant Professor in Research Institute for Wakan-yaku, Toyama Medical and Pharmaceutical University. She moved to Research Center for Ethnomedicines, Institute of Natural Medicine, Toyama Medical and Pharmaceutical University in 1996. From Nov. 1997, she worked at National Institute of Health (USA) for 4 months. She became an Associate Professor and Head of Division at of Neuromedical Science, Institute of Natural Medicine, University of Toyama in 2010, and a Full Professor and Head of Section of Neuromedical Science in 2017. Current Position is a Full Professor/Vice Director of Institute of Natural Medicine, University of Toyama. She is engaged in research primarily focused on natural medicines, aiming to develop novel therapeutic approaches for refractory neurodegenerative diseases such as dementia, spinal cord injury, degenerative cervical myelopathy and glaucoma. She is also advancing clinical studies based on the outcomes of foundational research, with a keen awareness towards eventual societal implementation of our findings.

Jae-Won Jung is a doctoral student at the Section of Neuromedical Science, Institute of Natural Medicine, University of Toyama. She is researching the development of new fundamental therapeutics for Alzheimer's disease (AD) by utilizing unused parts of medicinal plants. The goal of her research is to restore neural circuits and identify potential active components in these extracts, with the aim of contributing to the advancement of AD treatments.

Dr. Igor Iezhitsa has over 25 years of experience in pharmacology, with a career dedicated to both academia and research. He earned his PhD in Pharmacology from Volgograd State Medical University (Russia) in 1998, followed by a Doctor of Biological Science (Dr. Sci. Biol.) degree from the same institution in 2008. From 1994 to 2000, Dr. Igor was instrumental in preclinical studies of a novel class of CNS stimulants at Volgograd State Medical University. Since then, he has conducted extensive screening and preclinical evaluation of new pharmacological compounds. In 2009, Dr. Igor joined the Faculty of Medicine at Universiti Teknologi MARA (UiTM), Malaysia, as an Associate Professor of Pharmacology. He was a key figure in establishing the Centre for Neuroscience (NeuRon) at UiTM in 2013, leading the center from 2015 to 2020. He currently serves as Professor of Pharmacology at the School of Medicine, International Medical University. Dr. Igor’s research interests include neuropharmacology, neuroprotection, toxicology, and ocular pharmacology. He has published over 110 articles in indexed journals and authored five books and chapters.

Dr. Gean obtained his PhD in the Department of Pharmacology and Toxicology, University of Texas at Galveston in 1986 by establishing the amygdala slice preparation to investigate epileptic mechanisms. He is the Chair professor of Pharmacology at National Cheng Kung University, Taiwan and Former-President of the Pharmacological Society in Taiwan. Currently, Dr Gean is primarily engaged in researches of neuropsychiatric disorders, drug addiction and learning and memory.

Antonius Nugraha Widhi Pratama is a third-year PhD candidate and casual academic staff at Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Australia. He is also a lecturer at the Faculty of Pharmacy, Universitas Jember, Indonesia. Throughout his academic journey, Antonius received several scholarships and grants from Indonesia and Australia. His research interests are in social and administrative pharmacy and public health pharmacy. His current PhD project is about self-care needs assessment among international travellers in Indonesia and the readiness of Indonesian community pharmacies to facilitate self-care for the travellers. Antonius can be contacted at a.pratama@sydney.edu.au or anton.farmasi@unej.ac.id.

I am Yuzhang Li, a PhD student at the University of Queensland. My research focuses on developing compound nanoformulations to treat biofilm-associated bacterial infections. I aim to enhance the effectiveness of antimicrobial treatments by refining therapeutic strategies and exploring innovative solutions. I deeply value collaboration and enjoy connecting with fellow researchers in related fields. I look forward to engaging with others to exchange insights. I am also interested in exploring opportunities to bridge the gap between academic research and industrial applications.

Kirsten is a registered pharmacist with a rich background in research and medication supply. She holds a Master of Research in Pharmacy and has led various projects, including those for the International Pharmaceutical Federation, which resulted in peer-reviewed publications and pharmacy advocacy reports. Her work has been presented at both national and international conferences, where it has influenced global pharmacy decision-makers. As a clinician, Kirsten has specialised expertise in medication supply, ranging from procurement to robotic dispensing and high-risk medication management, across both community and hospital settings. She has a strong interest in implementation and multidisciplinary research and is eager to contribute further in this field.

Hafsa Hersi, BBiomedSci (Hon.), is a PhD candidate at Bond University on the Gold Coast, currently in the final year of her doctoral studies. Her research focuses on cancer therapeutics derived from natural products, specifically investigating the in-vitro effects of 6-(Methylsulfinyl)hexyl isothiocyanate from Wasabi and glycyrrhetinic acid from licorice root in the treatment of pediatric glioblastoma. This research is being conducted in collaboration with Meijo University, Nagoya, Japan. In addition to her research, Hafsa has extensive experience teaching various Biomedical Science and Medicine subjects, as well as training and mentoring students in laboratory-based research projects.

Research: I am a Third-year PhD student enrolled at the University of South Australia. My research explores how clinical pharmacy governance can be informed and improved using routinely collected electronic data in Australian hospitals. Personal History: I was born in the Democratic Republic of Congo and lived there until age five. I have grown up and currently live in Adelaide, South Australia. Education: I completed the Bachelor of Pharmacy (Honours) program in 2020 at the University of South Australia for my undergraduate studies. Occupation: I gained registration as a pharmacist in 2021 and I have been working as a rotational clinical pharmacist at the Modbury Hospital in South Australia since then.

Tark is a 4th year undergraduate pharmacy honours student at the University of Sydney. His honours project this year focussed on CYP2C19-guided antiplatelet therapy and the value it can provide within clinical care. Tark has also worked across community and hospital pharmacy during the 4 years of his degree and is looking forward to internship next year as the next step towards becoming a registered pharmacist.

Dr Alene is a Research Fellow at the Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences. She is currently working on clinical practice guideline development and research implementation. Previously, she has been involved in various public health projects, particularly in health financing and non-communicable disease service enhancement. She has experience using research methodologies such as evidence synthesis, qualitative research, and preference elicitation methods.

Siniti is a fourth-year pharmacy student at the University of Sydney (USYD). She is currently undergoing her Honours research project in the Western NSW Local Health District where she is exploring a virtual medication-centred pharmacy-led intervention that aims to support patients during their transition from hospital to home. Siniti works part-time at a local pharmacy in North Sydney and had the exciting opportunity to learn about toxicovigilance in India. She is interested in exploring the expanding scope of pharmacy within hospitals and the community.

Arian Ansardamavandi is a PhD candidate at the University of Melbourne, Department of Surgery, Austin Precinct, supervised by Dr. Hong He and Professor. Mehrdad Nikfarjam. With over ten years of research experience in cancer biology, including at the prestigious Pasteur Institute, Arian’s work has focused on advancing therapeutic strategies within this field. Since beginning his PhD in December 2021, he has concentrated on enhancing treatment efficacy in pancreatic cancer through the inhibition of p21-activated kinases (PAK), aiming to improve vascular normalization and modulate the tumor microenvironment. His research investigates immune cell activation, particularly involving T cells, dendritic cells, and M1/M2 macrophages, to foster an effective anti-tumor response. Arian has authored five ISI journal publications so far, with his most recent work, "PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response," contributing valuable insights into the potential for targeted therapeutic responses in cancer treatment. For a full list of publications, please visit his Google Scholar profile.

Lakeesha Sandamali Liyanage is currently pursuing a PhD at the University of Canberra. She earned her Bachelor of Pharmacy degree from the University of Ruhuna, Sri Lanka, in 2016. With a diverse career as a hospital pharmacist, community pharmacist, and academic, she has demonstrated a strong commitment to advancing the field of pharmacy. Her research interests focus on pharmacy practice, the quality use of medicines, and pharmacy education. Lakeesha has actively contributed to her field by presenting her research at multiple conferences and is passionate about fostering collaboration and innovation in pharmacy to improve patient outcomes.

Renate Roeterink is a Ph.D. candidate in Biomedical Engineering at the University of Melbourne, enrolled in a joint program with KU Leuven. With a background in biology and biofabrication, she is interested in combining applied molecular biology with microfluidic systems to explore mechanosensitive ion channels and G-Protein Coupled Receptors (GPCRs).

I am a PhD candidate at QUT, as well as a registered pharmacist and higher education academic in Sri Lanka. My research interests are centered on pharmacy practice-based research

Muhaimin Habib is a PhD student at the University of Queensland's School of Pharmacy in Drug Discovery, specializing in analytical chemistry, quality control, and pharmaceutical formulation. With a solid background in the pharmaceutical industry as qualified chemist and pharmacologist, Muhaimin has previously worked as a Quality Control Analyst at DBL Pharmaceuticals Ltd. and as a Clinical Trial Associate at IQVIA. He holds a Bachelor of Science from Monash University with a major in chemistry and pharmacology and a Master of Pharmaceutical Industry Practice from the University of Queensland. His research and professional endeavors are driven by a commitment to advancing pharmaceutical sciences and improving drug development processes.

Arsalan Yousuf is Lecturer in Sydney Pharmacy School, University of Sydney. His research focusses on Pain signaling via membrane GPCRS and ion channels and hunting down small molecules and conotoxins. Arsalan has a background in neuroscience and electrophysiology techniques.

Toni is a PhD student at the University of Sydney, School of Pharmacy. Her research is focused on understanding factors which contribute to the variability in urate response to gout medications and ovarian response to IVF medications (supervised by Dr. Sophie Stocker). She has received two awards for oral conference presentations.

Li Zhang, Ph D., Researcher of the Drug Crystal Research Center in Institute of Materia Medica, Quality director of the National Center for Drug and Metabolites Analysis and Research in Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College. She’s research direction is new technologies and methods for drug analysis for the prevention and treatment of cardiovascular and cerebrovascular diseases, pulmonary hypertension and diabetes vascular diseases. She Led the projects such as the General Program of National Natural Science Foundation, Shandong Province Key R&D Plan and mainly participated in research tasks such as Technology Major Special Projects and National Key R&D Plan. As the third person to complete the creation of “Establishment and Application of Key Technology System for Chemical Drug Crystallization”, it won the first prize of Beijing Science and Technology Award in 2014 and the second prize of National Science and Technology Progress Award in 2016. Published 40 research papers in the past 5 years, including 21 SCI papers, and applied for 28 invention patents, including 20 invention patent authorizations.

Yang Lyu, Researcher of the Drug Crystal Research Center in Institute of Materia Medica, the director of the National Center for Drug and Metabolites Analysis and Research, and the director of the Drug Crystal Research Center in the Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College. Her research directions include: drug quality analysis research, research on polymorphic forms of innovative and generic drugs, research on drug standards and reference materials, research on new technologies and methods for drug analysis, and research on three-dimensional structures of drugs and organisms. As the project leader, she presided over and undertaken nearly 20 national and provincial-level scientific research projects, including key projects for scientific and technological basic work, major new drug creation, scientific and technological major projects, comprehensive platform for major new drug creation, subsidy projects for major new drug creation by the Ministry of Science and Technology, and national key research and development plans. In the past 5 years, 85 research papers have been published. As the pharmaceutical leader, completed 8 national Class 1 new drug research and development projects. The chief editor has published two monographs. Received 90 Chinese invention patents and 2 PCT patents. Received 2 national second prizes for scientific and technological progress and 19 provincial and ministerial level awards. Led the formulation of 7 national technical standards and obtained 216 national level standard substances for measurement of drugs and active ingredients.

Benson is a PhD candidate at the Sydney Pharmacy School. His primary areas of research interest include clinical pharmacy, pharmacoepidemiology and health services research. He is also a registered pharmacist with experience in both community and hospital pharmacy

Dr Sellers has forged a distinguished academic career combining research and teaching at leading universities and hospitals in the United Kingdom. Focussing her research interests on the physiological and pharmacological function of smooth muscle, she has collaborated with fellow research scientists to relate her findings to medical disorders such as overactive bladder function and the complications of diabetes. Complementing her research portfolio, Dr Sellers has taught undergraduate and postgraduate subjects at Sheffield Hallam University, the University of Sheffield and the University of Manchester prior to joining Bond University's Faculty of Health Sciences and Medicine in 2009